Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021

Published on December 30, 2021

This report describes interim estimate of vaccine effectiveness among adolescents who received the COVID-19 Pfizer-BioNTech vaccine.